New Blueprint Is Helping Medical Device Companies Bypass GPOs, Barriers To Entry

Navigating the complexities of GPOs and hospital adoption resistance, the Stakeholder Engagement Blueprint accelerates market access for cutting-edge medical technologies.

Discover how Zane Myers Company can help you overcome the barriers to market entry at https://zanemyers.com  

Stakeholder Engagement Blueprint | Zane Myers Company

In today’s rapidly evolving healthcare landscape, innovation in medical technology is at an all-time high, with breakthroughs promising significant improvements in patient outcomes and hospital efficiencies. However, the road from innovation to adoption is fraught with challenges, particularly for smaller and mid-sized companies that don’t have the clout of industry giants.

“GPOs prioritize contract compliance over innovation, often resisting new technologies that aren’t part of their existing agreements because their financial incentives are tied to maintaining sales of contracted items,” said Zane Myers, founder of Zane Myers Company.

Recognizing these challenges, Zane Myers Company has introduced its Stakeholder Engagement Blueprint, a systematic approach designed to bypass these barriers and expedite the adoption of innovative medical devices within healthcare systems across the country. The Blueprint provides a pathway for medical device companies to directly connect with key decision-makers and clinicians, ensuring that groundbreaking technologies don’t get lost in the shuffle of bureaucratic resistance.

The Complexities of GPOs

“GPOs have a strong hold on purchasing decisions within hospitals, often stifling innovation by making it difficult for new and potentially life-saving technologies to be considered,” said Zane Myers. “Our Stakeholder Engagement Blueprint opens doors that were previously closed, allowing companies to present their innovations directly to the people who need them most—the clinicians.”

The Stakeholder Engagement Blueprint is particularly effective in addressing the problem of innovation adoption in healthcare, where the process of building trust and gaining consensus among stakeholders can be slow and resource-intensive. By leveraging targeted outreach, video testimonials from respected clinicians, and a dedicated follow-up team, the Blueprint accelerates the sales cycle, reduces the cost per sale, and ultimately drives faster, more profitable growth for medical device companies.

Key Features of the Stakeholder Engagement Blueprint include:

   •Direct Access to Clinicians: Bypassing GPOs and administrative roadblocks, the Blueprint ensures that innovations reach the clinicians who are most likely to champion them.

   •Accelerated Trust-Building: Through peer-to-peer video endorsements, the Blueprint rapidly establishes credibility and trust, a process that traditionally takes months or even years.

   •Comprehensive Support: From initial outreach to securing appointments, the Blueprint provides a complete system for engaging healthcare stakeholders and driving adoption.

The Zane Myers Company is committed to helping medical device companies overcome the traditional barriers to market entry, enabling them to bring their innovative technologies to the forefront of healthcare. With the Stakeholder Engagement Blueprint, companies can navigate the complexities of the healthcare system more effectively and ensure that their products have the impact they were designed to achieve.

For more information, contact Zane Myers directly at [email protected] or visit https://zanemyers.com